original ) (raw )Characterization of simian immunodeficiency virus-specific T-cell-mediated cytotoxic response of infected rhesus macaques
Thomas Pertel
AIDS, 1989
View PDFchevron_right
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection
Murray Gardner
Journal of Virology, 1993
View PDFchevron_right
Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus
Karin Metzner
Journal of General Virology, 2005
View PDFchevron_right
Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)
Erling Rud
Journal of virology, 1995
View PDFchevron_right
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Fred Peyerl
Nature, 2002
View PDFchevron_right
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm
Andrea Geraci
AIDS, 1998
View PDFchevron_right
Immunological and Virological Analyses of Rhesus Macaques Immunized with Chimpanzee Adenoviruses Expressing the Simian Immunodeficiency Virus Gag/Tat Fusion Protein and Challenged Intrarectally with Repeated Low Doses of SIVmac
Sarah Ratcliffe
Journal of Virology, 2013
View PDFchevron_right
Protection of Rhesus Monkeys against Infection with Minimally Pathogenic Simian-Human Immunodeficiency Virus: Correlations with Neutralizing Antibodies and Cytotoxic T Cells
Anil Choudhary
Journal of Virology, 2005
View PDFchevron_right
Simian Immunodeficiency Virus DNA Vaccine Trial in Macaques
Farah Mustafa
Annals of the New York Academy of Sciences, 1995
View PDFchevron_right
Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge
Raija Ahmed
Journal of General Virology, 1999
View PDFchevron_right
Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge
Vinamra Chaturvedi
Vaccine, 1993
View PDFchevron_right
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara
jlh66@cam.ac.uk Heeney
Vaccine, 2001
View PDFchevron_right
Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial
Mangala Rao
Journal of Virology, 2013
View PDFchevron_right
Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses
George Pavlakis
The Journal of Immunology, 2002
View PDFchevron_right
Passive Immunotherapy in Simian Immunodeficiency Virus-Infected Macaques Accelerates the Development of Neutralizing Antibodies
Nancy Haigwood
Journal of Virology, 2004
View PDFchevron_right
Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques
Lesley Bergmeier
AIDS, 1998
View PDFchevron_right
Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques
M. Yasunami
Journal of General Virology, 2007
View PDFchevron_right
Protection of Macaques Against Pathogenic Simian/Human Immunodeficiency Virus 89.6 PD by Passive Transfer of Neutralizing Antibodies
T. Vancott
Journal of …, 1999
View PDFchevron_right
Immunization of Macaques with Single-Cycle Simian Immunodeficiency Virus (SIV) Stimulates Diverse Virus-Specific Immune Responses and Reduces Viral Loads after Challenge with SIVmac239
Angela Carville
Journal of Virology, 2005
View PDFchevron_right
Long-Term Control of Simian Immunodeficiency Virusmac251 Viremia to Undetectable Levels in Half of Infected Female Rhesus Macaques Nasally Vaccinated with Simian Immunodeficiency Virus DNA/Recombinant Modified Vaccinia Virus Ankara
Angela Carville
The Journal of Immunology, 2011
View PDFchevron_right
No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication
jlh66@cam.ac.uk Heeney
The Journal of general virology, 2010
View PDFchevron_right
Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques
Gary Landucci
Vaccine, 2011
View PDFchevron_right
Mucosal Th1‐ versus Th2‐Type Responses for Antibody‐ or Cell‐Mediated Immunity to Simian Immunodeficiency Virus in Rhesus Macaques
Shigetada Kawabata
The Journal of Infectious Diseases, 1999
View PDFchevron_right
Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239
Kathy Vielhuber
Journal of Virology, 2002
View PDFchevron_right
Neutralizing Antibody Responses in Macaques Induced by Human Immunodeficiency Virus Type 1 Monovalent or Trivalent Envelope Glycoproteins
Mark A . Lewis
PLoS ONE, 2013
View PDFchevron_right
Simian Immunodeficiency Virus-Induced CD4+T Cell Deficits in Cytokine Secretion Profile Are Dependent on Monkey Origin
Debbie Watry
Viral Immunology, 2006
View PDFchevron_right
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens
jlh66@cam.ac.uk Heeney
Journal of virology, 2009
View PDFchevron_right
Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques
Brian Foley
2006
View PDFchevron_right
Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques
Angelina Kaur
Journal of …, 1998
View PDFchevron_right
Simian Immunodeficiency Virus (SIV) gp130 Oligomers Protect Rhesus Macaques (Macaca mulatta) against the Infection with SIVmac32H Grown on T-Cells or Derivedex Vivo
Birgit Makoschey
Virology, 1996
View PDFchevron_right